STOCK TITAN

Blue Biofuels Inc Financials

BIOF
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Blue Biofuels Inc (BIOF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

Blue Biofuels Inc passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality
0.71x

For every $1 of reported earnings, Blue Biofuels Inc generates $0.71 in operating cash flow (-$1.0M OCF vs -$1.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV
Revenue
N/A
EBITDA
-$3.9M
YoY-28.2%

Blue Biofuels Inc's EBITDA was -$3.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.2% from the prior year.

Free Cash Flow
-$1.1M
YoY+43.1%

Blue Biofuels Inc generated -$1.1M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 43.1% from the prior year.

Net Income
-$1.4M
YoY+53.6%

Blue Biofuels Inc reported -$1.4M in net income in fiscal year 2024. This represents an increase of 53.6% from the prior year.

EPS (Diluted)
$-0.01
YoY+50.0%

Blue Biofuels Inc earned $-0.01 per diluted share (EPS) in fiscal year 2024. This represents an increase of 50.0% from the prior year.

Cash & Debt
$49K
YoY+19.0%
5Y CAGR-15.1%
10Y CAGR-0.0%

Blue Biofuels Inc held $49K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
308M
YoY+1.7%
5Y CAGR+7.0%
10Y CAGR+30.4%

Blue Biofuels Inc had 308M shares outstanding in fiscal year 2024. This represents an increase of 1.7% from the prior year.

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A
R&D Spending
$2.3M
YoY+25.9%
5Y CAGR+23.9%

Blue Biofuels Inc invested $2.3M in research and development in fiscal year 2024. This represents an increase of 25.9% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$71K
YoY-75.3%
10Y CAGR+21.6%

Blue Biofuels Inc invested $71K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 75.3% from the prior year.

BIOF Income Statement

Metric Q3'25 Q3'24 Q4'23 Q3'23 Q4'22 Q3'22 Q4'21 Q3'21
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $486K+18.2% $411K N/A $294K N/A $404K N/A $230K
SG&A Expenses $351K+47.9% $237K N/A $219K N/A $179K N/A $216K
Operating Income -$836K-29.1% -$648K N/A -$513K N/A -$583K N/A -$446K
Interest Expense N/A N/A N/A $7K N/A $7K N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$423K-122.6% $1.9M N/A -$332K N/A -$619K N/A -$454K
EPS (Diluted) $-0.00-116.7% $0.01 N/A $-0.00 N/A $-0.00 N/A N/A

BIOF Balance Sheet

Metric Q3'25 Q3'24 Q4'23 Q3'23 Q4'22 Q3'22 Q4'21 Q3'21
Total Assets $1.5M+7.0% $1.4M+34.9% $1.0M-17.6% $1.2M+13.0% $1.1M-17.8% $1.3M-26.8% $1.8M-11.2% $2.1M
Current Assets $107K+31.2% $81K+5.9% $77K-69.7% $254K-0.5% $255K-56.9% $592K-51.1% $1.2M-15.8% $1.4M
Cash & Equivalents $95K+95.1% $49K+19.0% $41K-51.6% $85K-60.0% $212K-58.0% $505K-56.6% $1.2M-14.3% $1.4M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $4.5M+7.3% $4.2M-7.7% $4.6M+5.7% $4.3M+25.4% $3.5M+0.4% $3.4M+6.6% $3.2M-0.1% $3.2M
Current Liabilities $2.4M+8.2% $2.2M+47.2% $1.5M+13.9% $1.3M+106.7% $639K+6.6% $599K+20.7% $496K+0.6% $493K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A $2.4M
Total Equity -$3.1M-7.4% -$2.8M+20.1% -$3.6M-15.2% -$3.1M-31.2% -$2.4M-12.1% -$2.1M-50.6% -$1.4M-19.5% -$1.2M
Retained Earnings -$58.8M-2.8% -$57.3M-2.5% -$55.8M-0.9% -$55.3M-4.8% -$52.8M-1.1% -$52.2M-6.9% -$48.8M-1.2% -$48.2M

BIOF Cash Flow Statement

Metric Q3'25 Q3'24 Q4'23 Q3'23 Q4'22 Q3'22 Q4'21 Q3'21
Operating Cash Flow -$154K+27.4% -$212K-100.1% -$106K+66.3% -$314K+30.2% -$450K-18.3% -$380K+14.0% -$442K+4.5% -$463K
Capital Expenditures -$67K N/A $6K $0-100.0% $76K+28.6% $59K+58.0% $38K-41.4% $64K
Free Cash Flow -$221K N/A -$112K+64.4% -$314K+40.4% -$526K-19.7% -$440K+8.3% -$480K+9.0% -$527K
Investing Cash Flow $66K+177.3% -$86K-572.5% -$13K+3.0% -$13K+87.0% -$101K-21.0% -$84K-122.5% -$38K+43.4% -$66K
Financing Cash Flow $175K-11.2% $197K+162.7% $75K-78.6% $350K+35.7% $258K-24.1% $340K+19.3% $285K+1040.0% $25K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

BIOF Financial Ratios

Metric Q3'25 Q3'24 Q4'23 Q3'23 Q4'22 Q3'22 Q4'21 Q3'21
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -28.4%-153.8pp 125.3% N/A -26.6% N/A -46.0% N/A -21.9%
Current Ratio 0.040.0 0.04-0.0 0.05-0.1 0.19-0.2 0.40-0.6 0.99-1.5 2.44-0.5 2.91
Debt-to-Equity -1.490.0 -1.49-0.2 -1.29+0.1 -1.40+0.1 -1.47+0.2 -1.64+0.7 -2.32+0.5 -2.77
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$2.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Is Blue Biofuels Inc profitable?

No, Blue Biofuels Inc (BIOF) reported a net income of -$1.4M in fiscal year 2024.

What is Blue Biofuels Inc's earnings per share (EPS)?

Blue Biofuels Inc (BIOF) reported diluted earnings per share of $-0.01 for fiscal year 2024. This represents a 50.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Blue Biofuels Inc's EBITDA?

Blue Biofuels Inc (BIOF) had EBITDA of -$3.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Blue Biofuels Inc's free cash flow?

Blue Biofuels Inc (BIOF) generated -$1.1M in free cash flow during fiscal year 2024. This represents a 43.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Blue Biofuels Inc's operating cash flow?

Blue Biofuels Inc (BIOF) generated -$1.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Blue Biofuels Inc's total assets?

Blue Biofuels Inc (BIOF) had $1.4M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Blue Biofuels Inc's capital expenditures?

Blue Biofuels Inc (BIOF) invested $71K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does Blue Biofuels Inc spend on research and development?

Blue Biofuels Inc (BIOF) invested $2.3M in research and development during fiscal year 2024.

How many shares does Blue Biofuels Inc have outstanding?

Blue Biofuels Inc (BIOF) had 308M shares outstanding as of fiscal year 2024.

What is Blue Biofuels Inc's current ratio?

Blue Biofuels Inc (BIOF) had a current ratio of 0.04 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Blue Biofuels Inc's debt-to-equity ratio?

Blue Biofuels Inc (BIOF) had a debt-to-equity ratio of -1.49 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Blue Biofuels Inc's return on assets (ROA)?

Blue Biofuels Inc (BIOF) had a return on assets of -102.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Blue Biofuels Inc's cash runway?

Based on fiscal year 2024 data, Blue Biofuels Inc (BIOF) had $49K in cash against an annual operating cash burn of $1.0M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Blue Biofuels Inc's debt-to-equity ratio negative or unusual?

Blue Biofuels Inc (BIOF) has negative shareholder equity of -$2.8M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Blue Biofuels Inc's Piotroski F-Score?

Blue Biofuels Inc (BIOF) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Blue Biofuels Inc's earnings high quality?

Blue Biofuels Inc (BIOF) has an earnings quality ratio of 0.71x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.